Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Immune Markers After Minimum Maintenance Dose

NCT03181009 is registered in ClinicalTrials.gov with Andrew Long, PharmD as lead sponsor.

NCT NCT03181009
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03181009 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Multi Oral Immunotherapy in Multi Food Allergic Patients to Test Immune Markers After Minimum Maintenance Dose
Lead sponsor
Andrew Long, PharmD
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2017
Completion date
January 30, 2019
Enrollment
60 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

food allergy